Up to £50,000.
8 October 2021
The Pilot project scheme is meant for novel research ideas that if successful would lead to a Major project or programme application to Alzheimer’s Research UK or other funding body.
This scheme also provides funds for small, translational research projects that show potential for an application to the Dementia Consortium or collaboration with the Alzheimer's Research UK Drug Discovery Alliance.
Provided to cover salaries (research, technical, students etc), equipment, animal costs and running costs (consumables, travel etc).
Duration: Up to two years.
8 October, 12pm
The lead applicant and point of contact must be based in a UK academic/research institution. However, the application can include researchers or institutions outside the UK. Co-applicants from small and medium enterprises are permitted.
The Lead Applicant is expected to have a contract (fixed term or tenure) which covers the proposed duration of the grant. Alzheimer's Research UK can contribute to salaries of co-applicants that do not have tenure or fixed term contracts but not to Lead Applicant salaries.
If the Lead Applicant does not hold a tenure appointment, the application must include a co-applicant that does.
If the project requires ethical approval and/or Home Office licences, the award is dependent upon the requisite approvals being granted.
Applicants seeking to obtain preliminary data before a collaboration with one or more of Alzheimer's Research UK’s Drug Discovery Institutes are required to hold early discussions with either one of the DDI Chief Scientific Officers (CSOs) regarding the suitability of the target and the data that is necessary to obtain before further work is initiated. A letter of support for the PPG work plan will be required of the collaborating DDI CSO(s) with the application.
Applicants aiming to gain preliminary data to support an Expression of Interest submission to the Dementia Consortium are not required to obtain a letter of support from Evotec. However, applicants will be asked to justify how the outcomes of their proposals would fit within the remit of a future Dementia Consortium project.
This scheme is not designed to cover:
- Clinical trials and opportunities to research ‘add ons’ to ongoing clinical trials
- Bridging funds for staff between posts/funding
DRI post-docs eligible for funding under the “UK DRI Pilot Studies Programme” are not eligible to apply for ARUK Pilot Project grants.
See our Eligibility Guidelines for further information.
Applications are made via our grant application website.
Grant schemes only appear on this website when the round is open and we are accepting new applications.
Alzheimer’s Research UK is a member of the Association of Medical Research Charities and follows their guidelines for best practice in peer review. Grants are awarded entirely on scientific merit in relation to Alzheimer’s Research UK’s remit and on the basis of open competition. The quality of the application and applicants is the key determinant of outcome, although the strength of the dementia research environment within the institution is also considered.
Grant Review Board (GRB) members are asked to read a subset of applications related to their area of expertise and provide a score based on whether an application should proceed to the next stage of review.
Applications for research studies that involve human subjects require lay review. Applicants are requested to complete a lay summary of their application which is sent to lay review volunteers for comments. The comments made by lay reviewers are made available to the GRB members.
Discussion in meeting
Each application is allocated to two GRB members, based roughly on their areas of expertise. The two members will present the application to the rest of the board, including any relevant information from external reviews or applicant responses. A short discussion will follow before the GRB score the application. Applications for each grant scheme are ranked by their average score and recommendations for funding are made.
Those applications recommended for funding by the GRB are presented to the trustees for final approval.
In the last three years Alzheimer’s Research UK has received 162 applications for Pilot Project grants. 37 of these projects were awarded funding.
The terms and conditions of grant differ for each grant scheme and contracts are drawn up individually once the grants have been awarded.
All grant holders are expected to report on the progress of their project on a regular basis. Read more about our reporting requirements on the measuring impact page.
For more information about any of the grant schemes or the application process please contact the Research Team email@example.com or 0300 111 5555